Chronic hypoxia augments endothelin-B receptor-mediated vasodilation in isolated perfused rat lungs

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 276, Issue 2 20-2, 1999, Pages

  Muramatsu, Masashi ^a   Oka, Masahiko ^a   Morio, Yoshiteru ^a   Soma, Sanae ^a   Takahashi, Hideki ^a   Fukuchi, Yoshinosuke ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Endothelium derived hyperpolarizing factor; Nitric oxide; Potassium channels; Pulmonary hypertension

Indexed keywords

ENDOTHELIN B RECEPTOR; GLIBENCLAMIDE; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DENSITOMETRY; ENZYME INHIBITION; HYPOXIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LUNG PERFUSION; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; RECEPTOR UPREGULATION; STATISTICAL ANALYSIS; VASOCONSTRICTION; VASODILATATION;

EID: 0033024263     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1999.276.2.l358     Document Type: Article

References (32)

1. Arai, H., S. Hori, I. Aramori, H. Ohkubo, and S. Nakanishi. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990.
2. Barnes, P. J. Endothelins and pulmonary diseases. J. Appl. Physiol. 77: 1051-1059, 1994.
3. A-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1327-H1331, 1994.
4. Chen, S., Y. Chen, Q. C. Meng, J. Durand, V. S. DiCarlo, and S. Oparil. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J. Appl. Physiol. 79: 2122-2131, 1995.
5. De Nucci, G., R. Thomas, P. D'Orleans-Juste, E. Antunes, C. Walder, T. D. Warner, and J. R. Vane. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA 85: 9797-9800, 1988.
6. A-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am. J. Physiol. 269 (Lung Cell. Mol. Physiol. 13): L690-L697, 1995.
7. Eddahibi, S., D. Springall, M. Mannan, C. Carville, P. E. Chabrier, M. Levame, B. Raffestin, J. Polak, and S. Adnot. Dilator effect of endothelins in pulmonary circulation: changes associated with chronic hypoxia. Am. J. Physiol. 265 (Lung Cell. Mol. Physiol. 9): L571-L580, 1993.
8. Garland, C. J., F. Plane, B. K. Kemp, and T. M. Cocks. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol. Sci. 16: 23-30, 1995.
9. Hasunuma, K., D. M. Rodman, R. F. O'Brien, and I. F. McMurtry. Endothelin 1 causes pulmonary vasodilation in rats. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H48-H54, 1990.
10. Higashi, T., T. Ishizaki, K. Shigemori, T. Yamamura, and T. Nakai. Pharmacological characterization of endothelin-induced rat pulmonary arterial dilatation. Br. J. Pharmacol. 121: 782-786, 1997.
11. Isaacson, T. C., V. Hampl, E. K. Weir, D. P. Nelson, and S. L. Archer. Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J. Appl. Physiol. 76: 933-940, 1994.
12. Le Cras, T. D., C. Xue, A. Rengasamy, and R. A. Johns. Chronic hypoxia upregulates endothelial and inducible NO synthase gene and protein expression in rat lung. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14): L164-L170, 1996.
13. Levin, E. R. Endothelins. N. Engl. J. Med. 333: 356-363, 1995.
14. Li, H., S. Chen, Y. Chen, Q. C. Meng, J. Durand, S. Oparil, and T. S. Elton. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J. Appl. Physiol. 77: 1451-1459, 1994.
15. Lipton, H. L., G. A. Cohen, I. F. McMurtry, and A. L. Hyman. Pulmonary vasodilation to endothelin isopeptides in vivo is mediated by potassium channel activation. J. Appl. Physiol. 70: 947-952, 1991.
16. Maruyama, J., and K. Maruyama. Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of rats. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H2476-H2488, 1994.
17. Masuda, Y., C. Arakawa, T. Yamashita, M. Miyajima, K. Shigenobu, Y. Kasuya, and S. Tanaka. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein. Eur. J. Pharmacol. 195: 323-331, 1991.
18. Michael, J. R., and B. A. Markewitz. Endothelins and the lung. Am. J. Respir. Crit. Care Med. 154: 555-581, 1996.
19. + channel of vascular smooth muscle cells. FEBS Lett. 345: 47-49, 1994.
20. Muramatsu, M., D. M. Rodman, M. Oka, and I. F. McMurtry. Endothelin-1 mediates nitro-L-arginine vasoconstriction of hypertensive rat lungs. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L807-L812, 1997.
21. Muramatsu, M., R. C. Tyler, D. M. Rodman, and I. F. McMurtry. Thapsigargin stimulates increased NO activity in hypoxic hypertensive rat lungs and pulmonary arteries. J. Appl. Physiol. 80: 1336-1344, 1996.
22. Murphy, M. E., and J. E. Brayden. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J. Physiol. (Lond.) 486: 47-58, 1995.
23. Ohwada, A., H. Takahashi, I. Nagaoka, and S. Kira. Biliary glycoprotein mRNA expression is increased in primary lung cancer, especially in squamous cell carcinoma. Am. J. Respir. Cell Mol. Biol. 11: 214-220, 1994.
24. Resta, T. C., R. J. Gonzales, W. G. Dail, T. C. Sanders, and B. R. Walker. Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H806-H813, 1997.
25. Resta, T. C., and B. R. Walker. Chronic hypoxia selectively augments endothelium-dependent pulmonary arterial vasodilation. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H888-H896, 1996.
26. + channel-mediated relaxation. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L88-L94, 1992.
27. Rounds, S., and N. S. Hill. Pulmonary hypertensive diseases. Chest 85: 397-405, 1984.
28. Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735, 1990.
29. B receptor. Biochem. Biophys. Res. Commun. 184: 953-959, 1992.
30. Xue, C., A. Rengasamy, T. D. Le Cras, P. A. Koberna, G. C. Dailey, and R. A. Johns. Distribution of NOS in normoxic vs. hypoxic rat lung: upregulation of NOS by chronic hypoxia. Am. J. Physiol. 267 (Lung Cell Mol. Physiol. 11): L667-L678, 1994.
31. Yamaguchi., T., R. F. O'Brien, W. L. Hanson, W. W. Wagner, Jr., and I. F. McMurtry. Prostacyclin contributes to inhibition of hypoxic pulmonary vasoconstriction by alkalosis. Prostaglandins 38: 53-63, 1989.
32. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.